HIV-DHHS Guidelines

Разработчик: VirologyEd Consultants
Скачивания
Доход

Описание

Application Description: This application was developed with funding from the Northeast/Caribbean AIDS Education and Training Center Program and was designed for practicing clinicians to provide information on HIV medications and drug interactions with commonly co-prescribed primary care medications and HIV-HIV combinations. The four tabs at the bottom of the application include: HIV-Primary Care Interactions, HIV-HIV Interactions, Drug Metabolism, and Common Web Resources. The Common Web Resources tab contains links to external websites and phone numbers for information and national warmlines that provide clinical support with HIV care, substance use, Hepatitis C, and COVID‐19.

The data set for the drug interaction output for this application was developed using the Department of Health and Human Services Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and other various sources. The application was developed and launched under the direction of VirologyEd Consultants, LLC.

Disclaimer: This information is meant to be consumed by licensed professionals involved with patient care and used within their scope of practice. If you are not a licensed professional please consult appropriate medical professionals about questions you have when using this application. Please consult additional references when providing patient care as the authors cannot guarantee complete accuracy of all information contained in the application.

HRSA disclosure: This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1OHA29291, AIDS Education and Training Centers Program. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
Скрыть Показать больше...

Скриншоты

HIV-DHHS Guidelines Частые Вопросы

  • Приложение HIV-DHHS Guidelines бесплатное?

    Да, HIV-DHHS Guidelines полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли HIV-DHHS Guidelines фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит HIV-DHHS Guidelines?

    Приложение HIV-DHHS Guidelines бесплатное.

  • Сколько зарабатывает HIV-DHHS Guidelines?

    Чтобы получить оценку дохода приложения HIV-DHHS Guidelines и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Саудовская Аравия.
История оценок

HIV-DHHS Guidelines Отзывы Пользователей

Нет отзывов в Саудовская Аравия
Приложение пока не имеет отзывов в Саудовская Аравия.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

HIV-DHHS Guidelines Конкуренты

Name
BHIVA Guidelines
Anti-HIV Med
N/A
HIV Clinical Job Aids
HIV Care Tools
EACS
Guidelines 11.1 (2022)
WHO TB Guide
TB Knowledge Sharing Platform
Osteoporosis by AZoMedical
CDC Yellow Book
Travel Health Information
Pocket Spectrum - Antibiotics
N/A
Gilead Middle East Database

HIV-DHHS Guidelines Установки

30дн.

HIV-DHHS Guidelines Доход

30дн.

HIV-DHHS Guidelines Доходы и Загрузки

Получите ценные инсайты о производительности HIV-DHHS Guidelines с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.